Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8726
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review ; day:28 ; month:5 ; year:2021 ; pages:1-15
World journal of urology ; (28.5.2021), 1-15
- Creator
-
Laukhtina, Ekaterina
Sari Motlagh, Reza
Mori, Keiichiro
Quhal, Fahad
Schuettfort, Victor M.
Mostafaei, Hadi
Katayama, Satoshi
Grossmann, Nico C.
Ploussard, Guillaume
Karakiewicz, Pierre I.
Briganti, Alberto
Abufaraj, Mohammad
Enikeev, Dmitry
Pradere, Benjamin
Shariat, Shahrokh F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00345-021-03703-8
- URN
-
urn:nbn:de:101:1-2021092420284446655205
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Laukhtina, Ekaterina
- Sari Motlagh, Reza
- Mori, Keiichiro
- Quhal, Fahad
- Schuettfort, Victor M.
- Mostafaei, Hadi
- Katayama, Satoshi
- Grossmann, Nico C.
- Ploussard, Guillaume
- Karakiewicz, Pierre I.
- Briganti, Alberto
- Abufaraj, Mohammad
- Enikeev, Dmitry
- Pradere, Benjamin
- Shariat, Shahrokh F.
- SpringerLink (Online service)
Other Objects (12)
Focal therapy in intermediate- and high-risk prostate cancer
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Focal therapy in intermediate- and high-risk prostate cancer
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Focal therapy in intermediate- and high-risk prostate cancer
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review